Colgate-Palmolive Company $CL Shares Sold by Powers Advisory Group LLC

Powers Advisory Group LLC reduced its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 3.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 8,781 shares of the company’s stock after selling 267 shares during the quarter. Powers Advisory Group LLC’s holdings in Colgate-Palmolive were worth $798,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Westend Capital Management LLC grew its position in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 140 shares during the period. Cornerstone Planning Group LLC lifted its holdings in shares of Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after purchasing an additional 287 shares in the last quarter. Saudi Central Bank purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $29,000. Ransom Advisory Ltd purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $33,000. Finally, Y.D. More Investments Ltd purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $37,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of CL opened at $80.00 on Wednesday. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The company has a market capitalization of $64.66 billion, a price-to-earnings ratio of 22.47, a PEG ratio of 4.18 and a beta of 0.35. The company’s 50 day simple moving average is $83.89 and its 200 day simple moving average is $88.56. Colgate-Palmolive Company has a 1 year low of $78.76 and a 1 year high of $103.82.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.91 earnings per share. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.

Analyst Ratings Changes

Several analysts have issued reports on CL shares. Citigroup reduced their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. UBS Group reduced their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Barclays upped their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 15th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $97.73.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.